General Electric Company

GE HealthCare is a global leader in medical technology, pharmaceutical diagnostics, and digital solutions, having spun off from the General Electric Company in early 2023. The company operates through four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, providing essential tools for precision care. Its Pharmaceutical Diagnostics division is a major player in the life sciences sector, developing and manufacturing contrast media and molecular imaging agents used in medical imaging procedures worldwide. GE HealthCare's portfolio includes advanced MRI and CT systems, as well as radiopharmaceuticals like Vizamyl and DaTscan for neurology and oncology. The company is increasingly focused on integrating artificial intelligence through its Edison platform to enhance clinical workflows and patient outcomes.